Caspase-independent cell death in T lymphocytes

Nature Immunology

Volumn 4, Issue 5, 2003, Pages 416-423

  Jäättelä, Marja ^a   Tschopp, Jürg ^b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE; LYSOZYME; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; AUTOIMMUNITY; CELL DEATH; CELL MEMBRANE PERMEABILITY; ENDOPLASMIC RETICULUM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CALCIUM SIGNALING; CASPASES; CELL DEATH; ENDOPLASMIC RETICULUM; HUMANS; LYSOSOMES; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; T-LYMPHOCYTES;

EID: 0038731167     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0503-416     Document Type: Review

References (125)

1. Kerr, J.F.R., Wyllie, A.H. & Currie, A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
2. Strasser, A., O'Connor, L. & Dixit, V.M. Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245 (2000).
3. Kaufmann, S.H. & Hengartner, M.O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11, 526-534 (2001).
4. Leist, M. & Jäättelä, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589-598 (2001).
5. Lockshin, R.A. & Zakeri, Z. Caspase-independent cell deaths. Curr. Opin. Cell Biol. 14, 727-733 (2002).
6. Zeuner, A., Emmo, A., Peschle, C. & De Maria, R. Caspase activation without death. Cell Death Differ. 6, 1075-1080 (1999).
7. Samali, A., Zhivotovsky, B., Jones, D., Nagata, S. & Orrenius, S. Apoptosis: cell death defined by caspase activation. Cell Death Differ. 6, 495-496 (1999).
8. Lockshin, R.A. & Zakeri, Z. Programmed cell death and apoptosis: origins of the theory. Nat. Rev. Mol. Cell Biol. 2, 545-550 (2001).
9. Susin, S.A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999).
10. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489-495 (2000).
11. Vercammen, D. et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188, 919-930 (1998).
12. Chi, S. et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18, 2281-2290 (1999).
13. Elliott, K., Ge, K., Du, W. & Prendergast, G.C. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19, 4669-4684 (2000).
14. Tolkovsky, A.M., Xue, L., Fletcher, G.C. & Borutaite, V. Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? Biochimie 84, 233-240 (2002).
15. Schulze-Osthoff, K. et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317-5323 (1992).
16. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485 (1998).
17. Ha, H.C. & Snyder, S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. USA 96, 13978-13982 (1999).
18. Saeki, K. et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ. 7, 1263-1269 (2000).
19. Denecker, G. et al. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 8, 829-840 (2001).
20. Chung, S., Gumienny, T.L., Hengartner, M.O. & Driscoll, M.A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat. Cell Biol. 2, 931-937 (2000).
21. Hirt, U.A., Gartner, F. & Leist, M. Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol. 164, 6520-6529 (2000).
22. Nylandsted, J. et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by hsp70 depletion. Cancer Res. 62, 7139-7142 (2002).
23. Ferri, K.R. & Kroemer, G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, E255-E263 (2001).
24. Mathiasen, I.S. & Jäättelä, M. Triggering caspase-independent cell death to combat cancer. Trends Mol. Med. 8, 212-220 (2002).
25. Von Ahsen, O., Waterhouse, N.J., Kuwana, T., Newmeyer, D.D. & Green, D.R. The 'harmless' release of cytochrome c. Cell Death Differ. 7, 1192-1199 (2000).
26. Lipton, S.A. & Bossy-Wetzel, E. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 111, 147-150 (2002).
27. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
28. Cregan, S.P. et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158, 507-517 (2002).
29. Yu, S.W. et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297, 259-263 (2002).
30. Joseph, B. et al. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 21, 65-77 (2002).
31. Li, L.Y., Luo, X. & Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95-99 (2001).
32. Suzuki, Y. et al. A serine protease, htra2, is released from the mitochondria and interacts with xiap, inducing cell death. Mol. Cell 8, 613-621 (2001).
33. Wang, X., Yang, C., Chai, J., Shi, Y. & Xue, D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298, 1587-1592 (2002).
34. Elmore, S.P., Qian, T., Grissom, S.F. & Lemasters, J.J. The mitochondrial permeability transition initiates autophagy in rat hepatocyces. FASEB J. 15, 2286-2287 (2001).
35. Xue, L., Fletcher, G.C. & Tolkovsky, A.M. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 11, 361-365 (2001).
36. Nylandsted, J. et al. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl. Acad. Sci. USA 97, 7871-7876 (2000).
37. Sperandio, S., de Belle, I. & Bredesen, D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97, 14376-14381 (2000).
38. Mattson, M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129 (2000).
39. Roberts, L.R. et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113, 1714-1726 (1997).
40. Roberg, K., Johansson, U. & Ollinger, K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 27, 1228-1237 (1999).
41. Roberg, K., Kagedal, K. & Ollinger, K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161, 89-96 (2002).
42. Guicciardi, M.E. et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest 106, 1127-1137 (2000).
43. Foghsgaard, L. et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1009 (2001).
44. Roberts, L.R., Adjei, P.N. & Gores, G.J. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem. Biophys. 30, 71-88 (1999).
45. van Eijk, M. & de Groot. C. Germinal center B cell apoptosis requires both caspase and cathepsin activity. J. Immunol. 163, 2478-2482 (1999).
46. Yuan, X.M. et al. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. USA 99, 6286-6291 (2002).
47. Katz, E. et al. B cell receptor-stimulated mitochondrial phospholipase A2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells. J. Immunol. 166, 137-147 (2001).
48. Roberg, K. & Ollinger, K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocyces. Am. J. Pathol. 152, 1151-1156 (1998).
49. Roberg, K. Relocalization of cathepsin D and cytochrome c early in apoptosis revealed by immunoelectron microscopy. Lab. Invest. 81, 149-158 (2001).
50. Kagedal, K., Zhao, M., Svensson, I. & Brunk, U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359, 335-343 (2001).
51. Foghsgaard, L., Lademann, U., Wissing, D., Poulsen, B. & Jaattela, M. Cathepsm B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells. J. Biol. Chem. 277, 39499-39506 (2002).
52. Gobeil, S., Boucher, C.C., Nadeau, D. & Poirier, G.G. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 8, 588-594 (2001).
53. Vancompernolle, K. et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438, 150-158 (1998).
54. Stoka, V. et al. Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276, 3149-3157 (2001).
55. Schotte, P., Declercq, W., Van Huffel, S., Vandenabeele, P. & Beyaert, R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442, 117-121 (1999).
56. Reggiori, F. & Klionsky, D.J. Autophagy in the eukaryotic cell. Eukaryot. Cell 1, 11-21 (2002).
57. Cataldo, A.M., Hamilton, D.J. & Nixon, R.A. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640, 68-80 (1994).
58. Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31 (1997).
59. Liang, X.H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676 (1999).
60. Xue, L., Fletcher, G.C. & Tolkovsky, A.M. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell Neurosci 14, 180-198 (1999).
61. Marino, G. et al. Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J. Biol. Chem. 278, 3671-3678 (2002).
62. Deiss, L.P., Galinka, H., Berissi, H., Cohen, O. & Kimchi, A. Catepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 15, 3861-3870 (1996).
63. Inbal, B., Bialik, S., Sabanay I., Shani, G. & Kimchi, A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol. 157, 455-468 (2002).
64. Caro, L.H., Plomp, P.J., Wolvetang, E.J., Kerkhof, C. & Meijer, A.J. 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur. J. Biochem 175, 325-329 (1988).
65. Wang, K.K. Calpain and caspase: can you tell the difference? Trends. Neurosci. 23, 20-26 (2000).
66. 3 involves up-regulation of the TNF receptor 1 and cathelpsin B. Int. J. Cancer 93, 224-231. (2001).
67. Mathiasen, I.S. et al. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem. 277, 30738-30745 (2002).
68. Bao, J.J. et al. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 62, 7264-7272 (2002).
69. Bodmer, J.L., Schneider, P. & Tschopp, J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26 (2002).
70. Locksley, R.M., Killeen, N. & Lenardo, M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501 (2001).
71. Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305-1308 (1998).
72. Siegel, R.M. et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357 (2000).
73. Kischkel, F.C. et al. Cytotoxicity-dependent Apo-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588 (1995).
74. Kischkel, F.C. et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276, 46639-46646 (2001).
75. Salvesen, G.S. & Dixit, V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96, 10964-10967 (1999).
76. Thome, M. & Tschopp, J. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1, 50-58 (2001).
77. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and ERK signaling pathways. Curr. Biol. 10, 640-648 (2000).
78. Chen, G. & Goeddel, D.V. TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635 (2002).
79. Sun, X., Yin, J., Starovasnik, M.A., Fairbrother, W.J. & Dixit, V.M. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J. Biol. Chem. 277, 9505-9511 (2002).
80. Yeh, W.C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958 (1998).
81. Zhang, J., Cado, D., Chen, A., Kabra, N.H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
82. Varfolomeev, E.E., Boldin, M.P., Goncharov, T.M. & Wallach, D. A potential mechanism of 'cross-talk' between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183, 1271-1275 (1996).
83. Vercammen, D., Vandenabeele, P., Beyaert, R., Declercq, W. & Fiers, W. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 9, 801-808 (1997).
84. Luschen, S., Ussat, S., Scherer, G., Kabelitz, D. & Adam-Klages, S. Sensitization to death receptor cytotoxicity by inhibition of Fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J. Biol. Chem. 275, 24670-24678 (2000).
85. Khwaja, A. & Tatton, L. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274, 36817-36823 (1999).
86. Vonarbourg, C. et al. Differential sensitivity of Jurkat and primary T cells to caspase-independent cell death triggered upon Fas stimulation. Eur J. Immunol. 32, 2376-2384 (2002).
87. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143, 1353-1360 (1998).
88. Kalai, M., Van Loo, G., Declercq, W. & Vandenabeele, P. Disruption of HSP90 function reverts TNF-induced necrosis to apoptosis. J. Biol. Chem. 278, 5622-5629 (2003).
89. Kelliher, M.A. et al, The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303 (1998).
90. Holler, N. et al. Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J. Immunol. Methods 237, 159-173 (2000).
91. Goossens, V. et al. Redox regulation of TNF signaling. Biofactors 10, 145-156 (1999).
92. Kudo, I. & Murakami, M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58 (2002).
93. Lin, L.L. et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278 (1993).
94. Waterman, W.H., Molski, T.F., Huang, C.K.,Adams, J.L. & Sha'afi, R.I. Tumour necrosis factor-α-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319, 17-20 (1996).
95. Kolesnick, R.N. & Kronke, M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643-665 (1998).
96. 2. FEBS Lett. 531, 18-22 (2002).
97. Uzzo, R.G. et al. Inhibition of NFκB induces caspase-independent cell death in human T lymphocytes. Biochem. Biophys. Res. Commun. 287, 895-899 (2001).
98. Hildeman, D.A. et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744 (1999).
99. Bidere, N. & Senik, A. Caspase-independent apoptotic pathways in T lymphocytes: a minireview. Apoptosis 6, 371-375 (2001).
100. Pettersen, R.D., Bernard, G., Olafsen, M.K., Pourtein, M. & Lie, S.O. CD99 signals caspase-independent T cell death. J. Immunol. 166, 4931-4942 (2001).
101. Doerfler, P., Forbush, K.A. & Perlmutter, R.M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164, 4071-4079 (2000).
102. Sayers, T.J. et al. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas. J. Leukoc Biol. 68, 81-86 (2000).
103. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).
104. Brunner, T. et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444 (1995).
105. Ju, S.T. et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448 (1995).
106. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M. & Krammer, P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441 (1995).
107. Zheng, L.X. et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351 (1995).
108. Scaffidi, C., Kirchhoff, S., Krammer, P.H. & Peter, M.E. Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11, 277-285 (1999).
109. Siegel, R.M., Chan, F.K., Chun, H.J. & Lenardo, M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1, 469-474 (2000).
110. Weih, F., Ryseck, R.P., Chen, L. & Bravo, R. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 93, 5533-5538 (1996).
111. Mittelstadt, P.R. & Ashwell, J.D. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18, 3744-3751 (1998).
112. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995).
113. Refaeli, Y., Van Parijs, L., London, C.A., Tschopp, J. & Abbas, A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623 (1998).
114. Krueger, A., Baumann, S., Krammer. P.H. & Kirchhoff, S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21, 8247-8254 (2001).
115. + T cells. Proc. Natl. Acad. Sci. USA 95, 12556-12561 (1998).
116. Davidson, W.F., Haudenschild, C., Kwon, J. & Williams, M.S.T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J. Immunol. 169, 6218-6230 (2002).
117. Smith, K.G., Strasser, A. & Vaux, D.L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176 (1996).
118. Van Parijs, L., Peterson, D.A. & Abbas, A.K. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8, 265-274 (1998).
119. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H. & Cory, S. Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
120. Scott, D.E., Kisch, W.J. & Steinberg, A.D. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J. Immunol. 150, 664-672 (1993).
121. Hildeman, D.A. et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16, 759-767 (2002).
122. Ferraro-Peyret. C., Quemeneur, L., Flacher, M., Revillard, J.P. & Genestier, L. Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. J. Immunol. 169, 4805-4810 (2002).
123. Kennedy, N.J., Kataoka, T., Tschopp, J. & Budd, R.C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896 (1999).
124. Alam, A., Cohen, L.Y., Aouad, S. & Sekaly, R.P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890 (1999).
125. Chun, H.J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395-399 (2002).